Provided by Tiger Fintech (Singapore) Pte. Ltd.

Estee Lauder

59.58
-0.0100-0.02%
Volume:1.77M
Turnover:104.72M
Market Cap:21.43B
PE:-30.61
High:59.74
Open:59.15
Low:58.41
Close:59.59
Loading ...

Seeking Clues to Estee Lauder (EL) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks
·
Yesterday

The US economy may have avoided a recession so far. Here's how that could change.

Yahoo Finance
·
Yesterday

Estée Lauder (EL) To Report Earnings Tomorrow: Here Is What To Expect

StockStory
·
Yesterday

The Estée Lauder Companies Inc. (EL): Among Large-Cap Stocks Insiders Were Buying in Q1 2025 Before Trump’s Tariff Shockwave

Insider Monkey
·
Yesterday

Estee Lauder Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
29 Apr

Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health

GlobeNewswire
·
29 Apr

RBC Capital Reaffirms Their Buy Rating on The Estée Lauder Companies (EL)

TIPRANKS
·
29 Apr

Jim Cramer Says Estee Lauder Companies (EL) One of the ‘Worst’ Companies I’ve Ever Invested In’

Insider Monkey
·
28 Apr

Church & Dwight to Report Q1 Earnings: What Investors Should Expect

Zacks
·
28 Apr

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial

GlobeNewswire
·
28 Apr

What to Watch in the Week Ahead and on Monday, April 28

Reuters
·
26 Apr

Evercore ISI Keeps Their Buy Rating on The Estée Lauder Companies (EL)

TIPRANKS
·
25 Apr

The Estée Lauder Companies to Webcast Discussion of Fiscal 2025 Third Quarter Results on May 1, 2025

Business Wire
·
25 Apr

EL Set to Release Q3 Earnings: Key Insights for Investors

Zacks
·
24 Apr

Estee Lauder (EL) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
24 Apr

How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises

Zacks
·
24 Apr

PMGC announces preliminary responses from U.S. FDA on EL-22

TIPRANKS
·
24 Apr

Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment

GlobeNewswire
·
24 Apr

Estee Lauder Is Maintained at Market Perform by Telsey Advisory Group

Dow Jones
·
24 Apr

Estee Lauder Cos. Cl A Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
23 Apr